Although further studies to validate our results are warranted, the observed effect of soluble Tie2 on the invasive pattern of glioma progression induced by anti-angiogenesis therapy prompts us to envision the possibility of using this strategy to render recurrent gliomas more surgically suitable and in turn improve patient survival. This evidence concerns the gene TEK and central nervous system cancer.